BioDuro and Cenra API Solutions forge global API manufacturing joint venture in Taiwan
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
Remidex manufactures micronutrient premixes and nutraceuticals,
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The company will address the observations and respond to the U.S. FDA within the stipulated timeframe
ShunzymeX leverages a proprietary protease to streamline purification
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Subscribe To Our Newsletter & Stay Updated